Literature DB >> 3050476

Adoptive immunotherapy in conjunction with bone marrow transplantation--amplification of natural host defence mechanisms against cancer by recombinant IL-2.

S Slavin1, A Eckerstein, L Weiss.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3050476

Source DB:  PubMed          Journal:  Nat Immun Cell Growth Regul        ISSN： 0254-7600


× No keyword cloud information.
  4 in total

Review 1.  Adoptive Immunotherapy For Leukemia With Ex vivo Expanded T Cells.

Authors:  Conrad R Y Cruz; Catherine M Bollard
Journal:  Curr Drug Targets       Date:  2017       Impact factor: 3.465

2.  In vivo administration of interleukin 2 plus T cell-depleted syngeneic marrow prevents graft-versus-host disease mortality and permits alloengraftment.

Authors:  M Sykes; M L Romick; K A Hoyles; D H Sachs
Journal:  J Exp Med       Date:  1990-03-01       Impact factor: 14.307

3.  Characterization of effector cells of graft vs leukemia following allogeneic bone marrow transplantation in mice inoculated with murine B-cell leukemia.

Authors:  L Weiss; M Weigensberg; S Morecki; S Bar; S Cobbold; H Waldmann; S Slavin
Journal:  Cancer Immunol Immunother       Date:  1990       Impact factor: 6.968

4.  Interleukin 2 prevents graft-versus-host disease while preserving the graft-versus-leukemia effect of allogeneic T cells.

Authors:  M Sykes; M L Romick; D H Sachs
Journal:  Proc Natl Acad Sci U S A       Date:  1990-08       Impact factor: 11.205
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.